Home / Import refusals / SCS-0360278-1/22/1

FDA Import Refusal SCS-0360278-1/22/1 — WALLACE PHARMACEUTICALS

WALLACE PHARMACEUTICALS — FEI 3017251504

The FDA refused shipment SCS-0360278-1/22/1 from WALLACE PHARMACEUTICALS (India) on May 22, 2025. The refused product falls under Drugs and Biologics — DICYCLOMINE HCL (ANTI-CHOLINERGIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 22, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61KCY16 DICYCLOMINE HCL (ANTI-CHOLINERGIC)
Charges
75

Other import refusals

  • 1FX-3441591-9/40002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-3441591-9/20002/3 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7263387-6/12/1 (Thu Jul 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-2170975-5/11/16 (Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7873934-6/21/1 (Mon Oct 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources